Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Nevada Business Herald.
Press releases published on October 20, 2025
Healthcare startups move fast, but execution can’t keep up, VenturiMatch turns strategy into growth in minutes
Venturous launches VenturiMatch, an AI-driven project platform connecting healthcare startups with seasoned executives—showcased at HLTH 2025. LAS VEGAS, NV, UNITED STATES, October 19, 2025 /EINPresswire.com/ -- Healthcare startups move fast, but …
ImmunOs Therapeutics Reports Promising Clinical Activity of IOS-1002 in Advanced Solid Tumors
Partial remissions and complete metabolic responses in PD-1/PD-L1-resistant cancers First-in-class multi-checkpoint inhibitor with robust efficacy and safety Combination arm with pembrolizumab (Keytruda®) in Australia near to completion by end 2025 …
Niu Technologies to Report Third Quarter 2025 Financial Results on November 17, 2025
BEIJING, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Niu Technologies (“NIU” or “the Company”) (NASDAQ: NIU), the world’s leading provider of smart urban mobility solutions, today announced that it will report its financial results for the third quarter 2025 before …
Entrepreneurs stay the course: 92% would choose this path again
Highlights from the national survey include: 74% of Canadian SMEs took steps to improve productivity this year; nearly one-third (30%) leveraged new technologies. While 86% report being in good health, 54% experienced emotional or mental exhaustion during …
L’entrepreneuriat résiste aux bouleversements: 92 % des entrepreneur·es choisiraient encore cette voie
Faits saillants: 74 % des PME canadiennes ont posé des gestes pour améliorer leur productivité cette année; près du tiers (30 %) ont tiré profit de nouvelles technologies Bien que 86 % se disent en bonne santé, 54 % affirment avoir ressenti un épuisement …
Perspective Therapeutics Presents Updated Interim Data from its Ongoing Phase 1/2a Clinical Trial of [212Pb]VMT-α-NET at the ESMO Congress 2025
Updated interim results with an additional ~19 weeks of follow-up since the prior update [212Pb]VMT-α-NET continues to be well-tolerated Objective Response Rate of 44% (7 of 16 patients) in Cohort 2 with SSTR2 expression in all tumors at median follow-up …
CoinEx Reinforces Transparency with Updated Proof of Reserve – October 2025
HONG KONG, Oct. 20, 2025 (GLOBE NEWSWIRE) -- CoinEx, a leading cryptocurrency exchange, has reaffirmed its commitment to transparency, security, and user trust with an updated proof of reserve as of October 10, 2025, at 07:00 (UTC). Maintaining a 1:1 …
Medela AG Introduces the New Motion InBra™ Wearable Breast Pump – Where Dependable Performance Meets Everyday Comfort
Baar, Switzerland, Oct. 20, 2025 (GLOBE NEWSWIRE) -- Medela, the brand trusted by millions of moms worldwide and the #1 brand in hospitals [1], today announced the launch of its newest innovation: the Motion InBra™, a highly efficient wearable breast pump …
PRESS RELEASE: CMB.TECH NV announces fixed income investor meetings
Antwerp, Oct. 20, 2025 (GLOBE NEWSWIRE) -- CMB.TECH NV (NYSE: CMBT, Euronext Brussels: CMBT and Euronext Oslo Børs: CMBTO) (“CMB.TECH”) has mandated Danske Bank, DNB Carnegie, Nordea Bank and Pareto Securities to arrange a series of fixed income investor …
Transgene and BioInvent’s Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors
BT-001 in combination with pembrolizumab is well tolerated and shows sustained antitumoral activity in both injected and non-injected lesions Data support further development of BT-001 in solid tumors to improve response to cancer immunotherapy Strasbourg, …
Le virus oncolytique armé BT-001, développé par Transgene et BioInvent, montre une activité antitumorale locale, à distance et durable chez des patients atteints de tumeurs avancées en échec thérapeutique
BT-001, administré en combinaison avec pembrolizumab, est bien toléré et présente une activité antitumorale persistante dans des lésions injectées et non-injectées Les résultats obtenus soutiennent la poursuite du développement de BT-001 dans les tumeurs …
Investa Launches Second Crowdcube Raise Following Record-Breaking 2024 Campaign
Investa Launches Second Crowdcube Raise Following Record-Breaking 2024 Campaign - UK fintech invites investors to join next growth phase as it enhances accessibility and streamlines options trading experience - London - Investa, the UK’s first zero- …
Press Release: ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors
ESMO: AlphaMedixTM phase 2 data support first-in-class potential of new targeted alpha therapy in gastroenteropancreatic neuroendocrine tumors New AlphaMedix data showed sustained and clinically meaningful responses across both RLT-naïve and RLT-exposed …
Communiqué de presse : ESMO : les données de l’essai de phase 2 soulignent le potentiel thérapeutique prometteur d’AlphaMedix™ en tant que pionnier de la nouvelle classe des alphathérapies ciblées contre les tumeurs neuroendocrines (...)
ESMO : les données de l’essai de phase 2 soulignent le potentiel thérapeutique prometteur d’AlphaMedix™ en tant que pionnier de la nouvelle classe des alphathérapies ciblées contre les tumeurs neuroendocrines gastro-entéro-pancréatiques (TNE-GEP) Les …
SOITEC: SOITEC AND CEA PARTNER TO DEVELOP AUTOMOTIVE CYBERSECURITY WITH ADVANCED FD-SOI TECHNOLOGY
SOITEC AND CEA PARTNER TO DEVELOP AUTOMOTIVE CYBERSECURITY WITH ADVANCED FD-SOI TECHNOLOGY Bernin (Grenoble), France, October 20, 2025 – As vehicles become increasingly software-defined and connected, ensuring robust hardware cybersecurity is ever more …
SOITEC : SOITEC ET LE CEA S’ASSOCIENT POUR FAIRE PROGRESSER LA CYBERSÉCURITÉ AUTOMOBILE GRÂCE À LA TECHNOLOGIE FD‑SOI
SOITEC ET LE CEA S’ASSOCIENT POUR FAIRE PROGRESSER LA CYBERSÉCURITÉ AUTOMOBILE GRÂCE À LA TECHNOLOGIE FD‑SOI Bernin (Grenoble), France, le 20 octobre 2025 – Avec des voitures qui intègrent de plus en plus de fonctions digitales, garantir une cybersécurité …
Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio
Leiden, the Netherlands, October 20, 2025: Pharming Group N.V. (“Pharming” or “the Company”) (Euronext: PHARM; Nasdaq: PHAR) today announced that 12 abstracts have been accepted for presentation at the American College of Allergy, Asthma …
Digital Identity Market to Exceed $80 Billion by 2030 Globally, Accelerated by Regulation & Hybrid Strategies
BASINGSTOKE, United Kingdom, Oct. 20, 2025 (GLOBE NEWSWIRE) -- A new study by global tech strategists Juniper Research has found that the digital identity market will grow from $51 billion in 2025 to $80 billion in 2030; representing a rapid growth rate of …
ST introduces new image sensors for industrial automation, security and retail applications
ST introduces new image sensors for industrial automation, security and retail applications Four new 5MP image sensors allow customers to optimize image capture with high speed, high detail with a single, flexible product instead of two chips New device …